|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Razzaghi H, Saraiya M, Thompson TD, Henley
SJ, Viens L and Wilson R: Five-year relative survival for human
papillomavirus-associated cancer sites. Cancer. 124:203–211. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee BH: Commentary on: ‘Comprehensive
molecular characterization of papillary renal-cell carcinoma.’
Cancer Genome Atlas Research Network. N Engl J Med. 2016 Jan
14;374((2)): 135–45. Urol Oncol. 35:578–579. 2017.
|
|
4
|
Forzati F, Federico A, Pallante P, Abbate
A, Esposito F, Malapelle U, Sepe R, Palma G, Troncone G, Scarfò M,
et al: CBX7 is a tumor suppressor in mice and humans. J Clin
Invest. 122:612–623. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iqbal MA, Siddiqui S, Ur Rehman A,
Siddiqui FA, Singh P, Kumar B and Saluja D: Multiomics integrative
analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic
reprogramming of breast cancer. Mol Oncol. 15:1450–1465. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang Z, Yan Y, Zhu Z, Liu J, He X,
Dalangood S, Li M, Tan M, Cai J, Tang P, et al: CBX7 suppresses
urinary bladder cancer progression via modulating AKR1B10-ERK
signaling. Cell Death Dis. 12:5372021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forzati F, De Martino M, Esposito F, Sepe
R, Pellecchia S, Malapelle U, Pellino G, Arra C and Fusco A:
miR-155 is positively regulated by CBX7 in mouse embryonic
fibroblasts and colon carcinomas, and targets the KRAS oncogene.
BMC Cancer. 17:1702017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng ZQ, Yuan GQ, Kang NL, Nie QQ, Zhang
GG and Wang Z: Chromobox 7/8 serve as independent indicators for
glioblastoma via promoting proliferation and invasion of glioma
cells. Front Neurol. 13:9120392022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu T, Wu Y, Hu Q, Zhang J, Nie E, Wu W,
Wang X, Wang Y and Liu N: CBX7 is a glioma prognostic marker and
induces G1/S arrest via the silencing of CCNE1. Oncotarget.
8:26637–26647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Xu Z, Zhou L and Hu K: Expression
profile and prognostic values of Chromobox family members in human
glioblastoma. Aging (Albany NY). 14:1910–1931. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ni S, Wang H, Zhu X, Wan C, Xu J, Lu C,
Xiao L, He J, Jiang C, Wang W and He Z: CBX7 suppresses cell
proliferation, migration, and invasion through the inhibition of
PTEN/Akt signaling in pancreatic cancer. Oncotarget. 8:8010–8021.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cacciola NA, Sepe R, Forzati F, Federico
A, Pellecchia S, Malapelle U, De Stefano A, Rocco D, Fusco A and
Pallante P: Restoration of CBX7 expression increases the
susceptibility of human lung carcinoma cells to irinotecan
treatment. Naunyn Schmiedebergs Arch Pharmacol. 388:1179–1186.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ni SJ, Zhao LQ, Wang XF, Wu ZH, Hua RX,
Wan CH, Zhang JY, Zhang XW, Huang MZ, Gan L, et al: CBX7 regulates
stem cell-like properties of gastric cancer cells via p16 and
AKT-NF-κB-miR-21 pathways. J Hematol Oncol. 11:172018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scott CL, Gil J, Hernando E,
Teruya-Feldstein J, Narita M, Martínez D, Visakorpi T, Mu D,
Cordon-Cardo C, Peters G, et al: Role of the chromobox protein CBX7
in lymphomagenesis. Proc Natl Acad Sci USA. 104:5389–5394. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gong L, Tang Y, Jiang L, Tang W and Luo S:
Regulation of circGOLPH3 and its binding protein CBX7 on the
proliferation and apoptosis of prostate cancer cells. Biosci Rep.
40:BSR202009362020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shinjo K, Yamashita Y, Yamamoto E,
Akatsuka S, Uno N, Kamiya A, Niimi K, Sakaguchi Y, Nagasaka T,
Takahashi T, et al: Expression of chromobox homolog 7 (CBX7) is
associated with poor prognosis in ovarian clear cell adenocarcinoma
via TRAIL-induced apoptotic pathway regulation. Int J Cancer.
135:308–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mosbah A, Barakat R, Nabiel Y and Barakat
G: High-risk and low-risk human papilloma virus in association to
spontaneous preterm labor: A case-control study in a tertiary
center, Egypt. J Matern Fetal Neonatal Med. 31:720–725. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rapisarda V, Borghesan M, Miguela V,
Encheva V, Snijders AP, Lujambio A and O'Loghlen A: Integrin Beta 3
regulates cellular senescence by activating the TGF-β pathway. Cell
Rep. 18:2480–2493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao L, Zhu H, Shu J, Gong D, Zheng D and
Gao J: Overexpression of TGF-β1 and SDF-1 in cervical
cancer-associated fibroblasts promotes cell growth, invasion and
migration. Arch Gynecol Obstet. 305:179–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You X, Wang Y, Meng J, Han S, Liu L, Sun
Y, Zhang J, Sun S, Li X, Sun W, et al: Exosomal miR-663b exposed to
TGF-β1 promotes cervical cancer metastasis and
epithelial-mesenchymal transition by targeting MGAT3. Oncol Rep.
45:122021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu R, Sun X, Chi Y, Zhou Q, Xiang H, Bosco
DB, Lai X, Qin C, So KF, Ren Y and Chen XM: Integrin β3/Akt
signaling contributes to platelet-induced hemangioendothelioma
growth. Sci Rep. 7:64552017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian P, Zhang C, Ma C, Ding L, Tao N, Ning
L, Wang Y, Yong X, Yan Q, Lin X, et al: Decreased chromobox
homologue 7 expression is associated with epithelial-mesenchymal
transition and poor prognosis in cervical cancer. Open Med (Wars).
16:410–418. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li R, Yan Q, Tian P, Wang Y, Wang J, Tao
N, Ning L, Lin X, Ding L, Liu J and Ma C: CBX7 inhibits cell growth
and motility and induces apoptosis in cervical cancer cells. Mol
Ther Oncolytics. 15:108–116. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Larionov A, Krause A and Miller W: A
standard curve based method for relative real time PCR data
processing. BMC Bioinformatics. 6:622005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao Z, Xu X, Liu Y, Chao H, Lin C, Li Z,
You Y, Liu N and Ji J: CBX7 negatively regulates migration and
invasion in glioma via Wnt/β-catenin pathway inactivation.
Oncotarget. 8:39048–39063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan C, Bei C, Zhu X, Zhang Y, Qin L and
Tan S: Single nucleotide polymorphisms of CBX4 and CBX7 decrease
the risk of hepatocellular carcinoma. Biomed Res Int.
2019:64368252019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pallante P, Forzati F, Federico A, Arra C
and Fusco A: Polycomb protein family member CBX7 plays a critical
role in cancer progression. Am J Cancer Res. 5:1594–1601.
2015.PubMed/NCBI
|
|
28
|
Huang Z, Liu J, Yang J, Yan Y, Yang C, He
X, Huang R, Tan M, Wu D, Yan J and Shen B: PDE4B induces
epithelial-to-mesenchymal transition in bladder cancer cells and is
transcriptionally suppressed by CBX7. Front Cell Dev Biol.
9:7830502021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng X, Guan L and Gao B: miRNA-19
promotes non-small-cell lung cancer cell proliferation via
inhibiting CBX7 expression. Onco Targets Ther. 11:8865–8874. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Federico A, Sepe R, Cozzolino F, Piccolo
C, Iannone C, Iacobucci I, Pucci P, Monti M and Fusco A: The
complex CBX7-PRMT1 has a critical role in regulating E-cadherin
gene expression and cell migration. Biochim Biophys Acta Gene Regul
Mech. 1862:509–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cicchini C, Amicone L, Alonzi T, Marchetti
A, Mancone C and Tripodi M: Molecular mechanisms controlling the
phenotype and the EMT/MET dynamics of hepatocyte. Liver Int.
35:302–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang C, Zhang J, Fok KL, Tsang LL, Ye M,
Liu J, Li F, Zhao AZ, Chan HC and Chen H: cd147 induces
epithelial-to-mesenchymal transition by disassembling cellular
apoptosis susceptibility Protein/E-Cadherin/β-Catenin complex in
human endometriosis. Am J Pathol. 188:1597–1607. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang N, Pan W, Li J, Cao T and Shen H:
Upregulated Circular RNA hsa_circ_0008433 regulates pathogenesis in
endometriosis via miRNA. Reprod Sci. 27:2002–2017. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vu T and Datta PK: Regulation of EMT in
colorectal cancer: A culprit in metastasis. Cancers (Basel).
9:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Loh CY, Chai JY, Tang TF, Wong WF, Sethi
G, Shanmugam MK, Chong PP and Looi CY: The E-Cadherin and
N-Cadherin switch in epithelial-to-mesenchymal transition:
signaling, therapeutic implications, and challenges. Cells.
8:11182019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luo R, Wei Y, Chen P, Zhang J, Wang L,
Wang W, Wang P and Tian W: Mesenchymal stem cells inhibit
epithelial-to-mesenchymal transition by modulating the IRE1α branch
of the endoplasmic reticulum stress response. Stem Cells Int.
2023:44837762023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
E M Eid E, S Alanazi A, Koosha S, A
Alrasheedy A, Azam F, M Taban I, Khalilullah H, Sadiq Al-Qubaisi M
and A Alshawsh M: Zerumbone induces apoptosis in breast cancer
cells by targeting αvβ3 integrin upon Co-administration with
TP5-iRGD peptide. Molecules. 24:25542019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dehghani-Ghobadi Z, Sheikh Hasani S,
Arefian E and Hossein G: Wnt5A and TGFβ1 Converges through YAP1
Activity and Integrin Alpha v Up-Regulation promoting epithelial to
mesenchymal transition in ovarian cancer cells and mesothelial cell
activation. Cells. 11:2372022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen M, Wu C, Fu Z and Liu S: ICAM1
promotes bone metastasis via integrin-mediated TGF-β/EMT signaling
in triple-negative breast cancer. Cancer Sci. 113:3751–3765. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shidal C, Singh NP, Nagarkatti P and
Nagarkatti M: MicroRNA-92 expression in CD133(+) melanoma stem
cells regulates immunosuppression in the tumor microenvironment via
integrin-dependent activation of TGFβ. Cancer Res. 79:3622–3635.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fullar A, Dudas J, Olah L, Hollósi P, Papp
Z, Sobel G, Karászi K, Paku S, Baghy K and Kovalszky I: Remodeling
of extracellular matrix by normal and tumor-associated fibroblasts
promotes cervical cancer progression. BMC Cancer. 15:2562015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ren J, Yu H, Li W, Jin X and Yan B:
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression
to reduce sensitivity to cisplatin in bladder cancer. Br J Cancer.
128:232–244. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen LY, Cheng CS, Qu C, Wang P, Chen H,
Meng ZQ and Chen Z: CBX3 promotes proliferation and regulates
glycolysis via suppressing FBP1 in pancreatic cancer. Biochem
Biophys Res Commun. 500:691–697. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang C, Su T, Xue Y, Cheng C, Lay FD,
McKee RA, Li M, Vashisht A, Wohlschlegel J, Novitch BG, et al: Cbx3
maintains lineage specificity during neural differentiation. Genes
Dev. 31:241–246. 2017. View Article : Google Scholar : PubMed/NCBI
|
